Enteric fever: Difference between revisions
From IDWiki
No edit summary |
(added doses) |
||
(2 intermediate revisions by the same user not shown) | |||
Line 2: | Line 2: | ||
===Microbiology=== |
===Microbiology=== |
||
*Caused by ''[[Salmonella enterica]]'' |
*Caused by ''[[Salmonella enterica]]'' subspecies ''enterica'' serotypes Typhi and Paratyphi |
||
*Virulence is related to Vi antigen and invasin protein |
*Virulence is related to Vi antigen and invasin protein |
||
Line 12: | Line 12: | ||
===Pathophysiology=== |
===Pathophysiology=== |
||
*Induction of pH-shock proteins and other adaptions allow ingested bacteria to pass through the |
*Induction of pH-shock proteins and other adaptions allow ingested bacteria to pass through the stomach and into the small intestine |
||
*There, they penetrate the intestinal mucosa followed by mononuclear cells, which transport them to |
*There, they penetrate the intestinal mucosa followed by mononuclear cells, which transport them to lymph nodes |
||
*They multiple within the reticuloendothelial system during the incubation period |
*They multiple within the reticuloendothelial system during the incubation period |
||
*After a threshold is reached, they disseminate to blood |
*After a threshold is reached, they disseminate to blood |
||
Line 30: | Line 30: | ||
**[[Myelitis]], [[psychosis]], [[ataxia]], [[parkinsonism]] |
**[[Myelitis]], [[psychosis]], [[ataxia]], [[parkinsonism]] |
||
**[[Meningoencephalopathy]] |
**[[Meningoencephalopathy]] |
||
**[[ |
**[[Abscess]] or [[empyema]] |
||
**[[Endocarditis]], [[myocarditis]], and [[pericarditis]] |
**[[Endocarditis]], [[myocarditis]], and [[pericarditis]] |
||
**[[Pneumonia]] |
**[[Pneumonia]] |
||
Line 38: | Line 38: | ||
==Diagnosis== |
==Diagnosis== |
||
*Blood cultures (large volume, like x4), stool cultures, bone marrow |
*Blood cultures (large volume, like x4), stool cultures, bone marrow biopsy (most sensitive) |
||
*Biopsy (most sensitive) |
|||
==Management== |
==Management== |
||
Line 45: | Line 44: | ||
*Treatment with third-generation cephalosporins like [[Is treated by::ceftriaxone]], stepped down to oral when improving and susceptibility data are available |
*Treatment with third-generation cephalosporins like [[Is treated by::ceftriaxone]], stepped down to oral when improving and susceptibility data are available |
||
**Alternatives are [[Is treated by::azithromycin]], followed by [[ampicillin]], [[TMP-SMX]], [[chloramphenicol]] |
**Alternatives are [[Is treated by::azithromycin]], followed by [[ampicillin]], [[TMP-SMX]], [[chloramphenicol]] |
||
**Avoid fluoroquinolones due to high resistance rate |
**Avoid [[fluoroquinolones]] due to high resistance rate |
||
*Duration 10 to 14 days |
*Duration 10 to 14 days |
||
**Can take 4 to 6 days to defervesce, even with treatment |
**Can take 4 to 6 days to defervesce, even with treatment |
||
*Monitor for relapse 2 to 3 weeks after treatment ends |
*Monitor for relapse 2 to 3 weeks after treatment ends |
||
{| class="wikitable" |
|||
!Antibiotic |
|||
!Dose |
|||
!Duration |
|||
|- |
|||
|[[azithromycin]] |
|||
|1 g p.o. once followed by 500 mg p.o. daily, or |
|||
1 g p.o. daily |
|||
|5 to 7 days |
|||
|- |
|||
|[[ciprofloxacin]] |
|||
|500 mg p.o. twice daily |
|||
| rowspan="2" |7 to 10 days |
|||
|- |
|||
|[[ofloxacin]] |
|||
|400 mg p.o. twice daily |
|||
|- |
|||
|[[ceftriaxone]] |
|||
|2 g IV daily |
|||
| rowspan="6" |10 to 14 days |
|||
|- |
|||
|[[cefotaxime]] |
|||
|1 to 2 g IV every 6 to 8 hours |
|||
|- |
|||
|[[cefixime]] |
|||
|200 mg p.o. twice daily |
|||
|- |
|||
|[[meropenem]] |
|||
|1 to 2 IV every 8 hours |
|||
|- |
|||
|[[TMP-SMX]] |
|||
|1 DS tablet p.o. twice daily |
|||
|- |
|||
|[[amoxicillin]] |
|||
|1 g p.o. three times daily |
|||
|- |
|||
|[[chlormaphenicol]] |
|||
|500 tp 750 mg p.o. four times daily |
|||
|14 to 21 days |
|||
|} |
|||
[[Category:Gram-negative bacilli]] |
[[Category:Gram-negative bacilli]] |
||
[[Category:Returned travellers]] |
[[Category:Returned travellers]] |
Latest revision as of 14:59, 13 May 2024
Background
Microbiology
- Caused by Salmonella enterica subspecies enterica serotypes Typhi and Paratyphi
- Virulence is related to Vi antigen and invasin protein
Epidemiology
- Fecal-oral transmission acquired from contaminated food, milk, or water
- Less than 5% of infected people become chronic carriers, with bacteria remaining in the gallbladder despite adequate antibiotic treatment
Pathophysiology
- Induction of pH-shock proteins and other adaptions allow ingested bacteria to pass through the stomach and into the small intestine
- There, they penetrate the intestinal mucosa followed by mononuclear cells, which transport them to lymph nodes
- They multiple within the reticuloendothelial system during the incubation period
- After a threshold is reached, they disseminate to blood
Clinical Manifestations
- Most commonly presents as fever in the returned traveller
- Incubation period 5 to 21 days
- Symptoms progress over weeks
- First week: fever, chills, bacteremia, relative bradycardia, headache
- Second week: abdominal pain, and a blanchable papular rash ("rose spots") may appear
- Third week: can progress to gastrointestinal perforation, hepatosplenomegaly, GI bleed, secondary bacteremia
- Constipation is more common in adults, while diarrhea is more common in children and people with HIV
- CBC shows leukopenia and anemia
- Extraintestinal manifestations are myriad
Diagnosis
- Blood cultures (large volume, like x4), stool cultures, bone marrow biopsy (most sensitive)
Management
- Treatment with third-generation cephalosporins like ceftriaxone, stepped down to oral when improving and susceptibility data are available
- Alternatives are azithromycin, followed by ampicillin, TMP-SMX, chloramphenicol
- Avoid fluoroquinolones due to high resistance rate
- Duration 10 to 14 days
- Can take 4 to 6 days to defervesce, even with treatment
- Monitor for relapse 2 to 3 weeks after treatment ends
Antibiotic | Dose | Duration |
---|---|---|
azithromycin | 1 g p.o. once followed by 500 mg p.o. daily, or
1 g p.o. daily |
5 to 7 days |
ciprofloxacin | 500 mg p.o. twice daily | 7 to 10 days |
ofloxacin | 400 mg p.o. twice daily | |
ceftriaxone | 2 g IV daily | 10 to 14 days |
cefotaxime | 1 to 2 g IV every 6 to 8 hours | |
cefixime | 200 mg p.o. twice daily | |
meropenem | 1 to 2 IV every 8 hours | |
TMP-SMX | 1 DS tablet p.o. twice daily | |
amoxicillin | 1 g p.o. three times daily | |
chlormaphenicol | 500 tp 750 mg p.o. four times daily | 14 to 21 days |